Image_10_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_15_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_5_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_13_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_11_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_14_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_6_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_1_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_4_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_12_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_2_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_3_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

Image_9_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

The <i>SKS1</i> ortholog <i>SHA3</i> is required for wild-type colony morphology in Spider media and in glucose-containing media in <i>Candida albicans</i>. by Cole Johnson (222835)

“…Treating growth in RPMI as a control, the ratio of biofilm formation in wild type cells in Spider media versus RPMI is 6.5 with a variance of 1.5, and for <i>sha3</i>Δ/<i>SHA3</i> mutants, the ratio is 2.1 with a variance of 0.9. …”

Photocatalytic and Superhydrophilic TiO2-SiO2 Coatings on Marble for Self-Cleaning Applications by Sutar, Rajaram S.

Get full text
Get full text

Data Sheet 2_Associations between gut microbiota and immune status in untreated B-cell lymphoma patients.zip by Jingxin Zhou (287185)

Data Sheet 3_Associations between gut microbiota and immune status in untreated B-cell lymphoma patients.zip by Jingxin Zhou (287185)

Data Sheet 1_Associations between gut microbiota and immune status in untreated B-cell lymphoma patients.zip by Jingxin Zhou (287185)

Data_Sheet_1_Tranexamic Acid Administered During Off-Pump Coronary Artery Bypass Graft Surgeries Achieves Good Safety Effects and Hemostasis.docx by Enshi Wang (12043937)

“…Therefore, the risk of total blood exposure [odds ratio (OR) = 0.50, 95% CI 0.47–0.54, p < 0.001] or blood component exposure (p < 0.001) was decreased significantly in the patients who administered TXA. …”

Results of the multi-armed bandit experiments. by Rachit Dubey (13199712)

“…<p><b>(a)</b> 10-armed bandit simulation where the mean of the 9 sub-optimal arms is drawn from a uniform distribution on range [−1, 0.9]. …”